Mar 15, 2023 / Chapters

Executive Summary (March 2023 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2023 / Press Releases

MedPAC releases March 2023 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 03, 2023 / Transcripts

March 2023 meeting transcript

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals, Post-Acute Care, Private Plans

Mar 03, 2023 / Presentations

Aligning fee-for-service payment rates across ambulatory settings

Research Areas:

Ambulatory Care Settings, Medicare Spending and Financing, Regional Issues

Mar 03, 2023 / Presentations

Favorable selection and future directions for Medicare Advantage payment policy

Research Areas:

Medicare Spending and Financing, Private Plans

Mar 02, 2023 / Presentations

Mandated report: Evaluation of a prototype design for a post-acute care prospective payment system

Research Areas:

Beneficiaries and Coverage, Medicare Spending and Financing, Post-Acute Care

Mar 02, 2023 / Presentations

Addressing the high prices of drugs covered under Medicare Part B

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing

Mar 02, 2023 / Presentations

Reforming Medicare’s wage index systems

Research Areas:

Hospitals, Medicare Spending and Financing, Regional Issues

Mar 01, 2023 / Comment Letters

MedPAC comment on CMS’s advance notice of methodological changes for CY 2024 for Medicare Advantage capitation rates and Part C and D payment policies

Research Areas:

Private Plans, Quality

Feb 10, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on policy and technical changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for 2024

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans